i3 Partners GmbH

SGDL Health SA revolutionizes genomic data management with advanced spatial computing and multidimensional indexing. Our secure, scalable, AI-driven solutions empower precision medicine and accelerate genomic research.

XEMPERIA, a spin-off from the University of Fribourg, is pioneering a groundbreaking approach to blood testing that leverages the body's immune response to detect breast cancer at its earliest and most treatable stage.

Parithera is pioneering an AI-ready, clinical-grade liquid biopsy platform for single-cell analysis. Our platform is ideally positioned to study cancer treatment resistance.